Non-alcoholic steatohepatitis (NASH) is a condition in which fat accumulates in the liver in people who drink little or no alcohol. Despite widespread R&D effort, no regulatory approved therapeutic drugs are available, because traditional preclinical models fail to predict the efficacy of potential drugs in humans.
In this infographic, we compare four preclinical NASH models: in vitro 2D models, in vitro 3D spheroid models, in vivo animal models and in vitro organ-on-a-chip models, highlighting the pros and cons of each.
[ui-tab title=”More information”]
- An introduction to non-alcoholic liver disease
- The pros and cons of various disease models
Illustration by Hannah Morton.
The post Infographic: Pros and cons of preclinical models of non-alcoholic steatohepatitis appeared first on BioTechniques.
Full BioTechniques Article here
Powered by WPeMatico